Prognostic value of tumor‐infiltrating lymphocytes and PD ‐ L1 expression in esophageal squamous cell carcinoma
Cancer Medicine · 2024
DOI: 10.1002/cam4.70179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Jie Hu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: B7-H1 Antigen, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Tumor cells (TC) participate in tumor progression by altering the immune responses in the tumor microenvironment. However, the clinical relevance and prognostic effect of PD‐L1 expression and tumor‐infiltrating lymphocytes (TILs) in esophageal squamous cell carcinoma (ESCC) are unknown. The purpose of this study was to investigate the interactions and clinical significance of PD‐L1 expression and TILs in ESCC.
Methods
Tissue specimens were collected from 126 patients with ESCC who underwent curative esophagectomy. Immunohistochemical analysis and multiplex immunofluorescence for CD4, CD8, CD25, FOXP3, and PD‐L1 in the tumor were used to identify multiple tumor‐infiltrating immune cells (TIIC), Tregs, and TC.
Results
PD‐L1 was expressed in tumor cells (PD‐L1 TC). PD‐L1 TIIC and PD‐L1 TC affected the biological behavior of TC. The positive expression rate of PD‐L1 TC and CD8 + TILs was 27.8% (35/126) and 31.7% (40/126), respectively. Kaplan–Meier analysis showed that overall survival (OS) was significantly associated with decreased CD8 + TILs and PD‐L1 TC‐positive expression, which promote ESCC progression and metastasis.
Conclusion
Tumor depth, CD8, and PD‐L1 TC were independent prognostic factors in ESCC, and a predictive nomogram with these three risk factors improved the accuracy of predicting OS in patients with ESCC after surgical resection. The conjoint analysis of multiple immune‐related factors is beneficial for stratifying patient survival risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
ORCID-Profile: Jie Hu
Zitieren
APA
Hu, J., Toyozumi, T., Murakami, K., Endo, S., Matsumoto, Y., Otsuka, R., Shiraishi, T., Iida, S., Morishita, H., Makiyama, T., Nishioka, Y., Uesato, M., Hayano, K., Nakano, A., & Matsubara, H. (2024). Prognostic value of tumor‐infiltrating lymphocytes and PD ‐ L1 expression in esophageal squamous cell carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.70179
Vancouver
Hu J, Toyozumi T, Murakami K, Endo S, Matsumoto Y, Otsuka R, et al. Prognostic value of tumor‐infiltrating lymphocytes and PD ‐ L1 expression in esophageal squamous cell carcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.70179
BibTeX
@article{Hu2024,
author = {Hu, Jie and Toyozumi, Takeshi and Murakami, Kentaro and Endo, Satoshi and Matsumoto, Yasunori and Otsuka, Ryota and Shiraishi, Tadashi and Iida, Shinichiro and Morishita, Hiroki and Makiyama, Tenshi and Nishioka, Yuri and Uesato, Masaya and Hayano, Koichi and Nakano, Akira and Matsubara, Hisahiro},
title = {Prognostic value of tumor‐infiltrating lymphocytes and PD ‐ L1 expression in esophageal squamous cell carcinoma},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70179}
}
EUVIMED